J. Safra Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Sell
81
-17
-17% -$2.09K ﹤0.01% 392
2026
Q1
$11.5K Buy
98
+66
+206% +$9.22K ﹤0.01% 361
2025
Q4
$5.24K Buy
32
+27
+540% +$4.23K ﹤0.01% 417
2025
Q3
$668 Buy
+5
New +$607 ﹤0.01% 458

Other funds holding RGEN

J. Safra Asset Management's RGEN Position: Q2 2026 in Review

J. Safra Asset Management reduced its Repligen (RGEN) stake by 17% in Q2 2026, selling an estimated $2.09K and leaving 81 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #392.

J. Safra Asset Management first reported a position in RGEN in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.5K in Q1 2026. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • J. Safra Asset Management held 81 shares of Repligen worth $11.1K as of Q2 2026.
  • J. Safra Asset Management sold 17 Repligen shares in Q2 2026, an estimated $2.09K.
  • Repligen made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #392 holding.
  • J. Safra Asset Management first reported a position in Repligen in Q3 2025 and has held it in 4 quarters since.
  • J. Safra Asset Management's Repligen position peaked at $11.5K in Q1 2026.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.